Skip to main content

Table 4 Dietary intakes of participants at baseline, week 4, and week 8.

From: The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial

 

Groups

    

Energy and nutrients intake

Synbiotics

(n = 34)

Placebo

(n = 33)

1P value

2P value

3P value

Energy

(Kcal/d)

Baseline

1538.81 ± 436.68

1694.89 ± 483.68

0.208

0.163

0.306

Week 4

1704.93 ± 412.79

1491.58 ± 483.68

Week 8

1740.15 ± 431.56

1420.33 ± 527.00

P value4

< 0.001

< 0.001

   

Carbohydrate

(gr/d)

Baseline

210.73 ± 58.64

216.19 ± 73.09

0.524

0.623

0.238

Week 4

228.10 ± 58.60

204.32 ± 68.73

Week 8

231.87 ± 61.71

194.04 ± 65.01

P value4

0.068

0.072

   

Protein

(gr/d)

Baseline

68.49 ± 13.99

61.97 ± 19.91

0.015

0.004

0.003

Week 4

70.77 ± 14.20

59.91 ± 18.89

Week 8

80.53 ± 14.21

62.18 ± 21.25

P value4

< 0.001

0.099

   

Fat (gr/d)

Baseline

63.10 ± 17.31

64.76 ± 19.53

0.059

0.041

0.064

Week 4

68.44 ± 20.90

54.40 ± 20.63

Week 8

67.40 ± 23.73

52.66 ± 21.19

P value4

0.060

< 0.001

Fiber (g/d)

Baseline

38.91 ± 17.77

36.44 ± 10.56

0.060

0.023

0.353

Week 4

38.20 ± 18.22

35.36 ± 8.66

Week 8

38.22 ± 18.41

33.59 ± 9.19

P value4

0.628

0.013

Saturated fatty acids (g/d)

Baseline

15.62 ± 4.61

15.78 ± 3.59

0.012

0.656

0.935

Week 4

15.39 ± 3.80

15.24 ± 3.09

Week 8

15.31 ± 3.87

15.51 ± 2.43

P value4

0.748

0.094

Poly unsaturated fatty acids (g/d)

Baseline

10.15 ± 5.92

11.95 ± 5.78

0.855

0.861

0.859

Week 4

10.97 ± 6.20

11.13 ± 6.78

Week 8

11.69 ± 6.03

10.55 ± 6.22

P value4

0.548

0.081

Mono unsaturated fatty acids (g/d)

Baseline

28.66 ± 10.58

31.03 ± 10.35

0.571

0.391

0.638

Week 4

29.39 ± 10.75

30.82 ± 10.93

Week 8

30.13 ± 10.88

30.15 ± 10.83

P value4

0.891

0.488

Trans fatty acids (g/d)

Baseline

0

0

1.000

1.000

1.000

Week 4

0

0

Week 8

0

0

P value4

1.000

1.000

cholesterol (g/d)

Baseline

204.33 ± 57.50

206.38 ± 62.10

0.080

0.814

0.668

Week 4

203.77 ± 56.33

211.01 ± 55.24

Week 8

186.64 ± 60.82

193.85 ± 52.38

P value4

0.061

0.073

Iron (mg/d)

Baseline

12.34 ± 1.58

12.50 ± 2.21

0.296

0.140

0.965

Week 4

12.57 ± 1.59

12.78 ± 1.50

Week 8

12.79 ± 1.31

12.39 ± 1.33

P value4

0.051

0.062

Magnesium (mg/d)

Baseline

310.50 ± 69.96

305.81 ± 80.48

0.132

0.410

0.412

Week 4

316.43 ± 83.57

295.46 ± 83.81

Week 8

301.74 ± 77.98

282.33 ± 83.84

P value4

0.337

0.062

Zinc (mg/d)

Baseline

6.91 ± 1.08

8.03 ± 1.53

0.025

0.101

0.745

Week 4

7.23 ± 1.05

7.55 ± 1.34

Week 8

7.35 ± 1.05

7.35 ± 1.37

P value4

0.074

0.082

Calcium (mg/d)

Baseline

568.44 ± 262.85

678.26 ± 239.02

< 0.001

< 0.001

0.079

Week 4

611.06 ± 282.22

614.42 ± 264.21

Week 8

765.52 ± 279.64

572.39 ± 228.17

P value4

< 0.001

0.001

Vitamin D (µg/d)

Baseline

1.36 ± 1.32

1.85 ± 1.68

0.385

0.103

0.741

Week 4

1.33 ± 1.29

1.62 ± 1.56

Week 8

2.58 ± 5.50

1.35 ± 1.52

P value4

0.428

0.092

Vitamin C (mg/d)

Baseline

71.18 ± 23.32

56.19 ± 28.20

< 0.001

< 0.001

< 0.001

Week 4

77.03 ± 25.88

55.33 ± 25.53

Week 8

84.49 ± 27.81

53.94 ± 26.49

P value4

< 0.001

0.287

Copper (mg/d)

Baseline

1.26 ± 0.35

1.19 ± 0.36

0.070

0.863

0.233

Week 4

1.16 ± 0.28

1.06 ± 0.23

Week 8

1.21 ± 0.32

1.13 ± 0.45

P value4

0.165

0.115

  1. data reported as mean ± SD
  2. Repeated Measures ANOVA was used to analysis of time-effect1, group-effect2, and time-group-effect3 between-groups comparison conducted via Repeated Measures ANOVA